Want to see HK:0809 full AI Analyst Report?
0809 Stock Chart & Stats
HK$0.06
>-HK$0.01(-1.00%)
At close: 4:00 PM EST
HK$0.06
>-HK$0.01(-1.00%)
Day’s Range― - ―
52-Week RangeHK$0.33 - HK$1.22
Previous CloseN/A
Volume370.00K
Average Volume (3M)8.43M
Market Cap
HK$557.16M
Enterprise ValueHK$2.20B
Total Cash (Recent Filing)HK$94.44M
Total Debt (Recent Filing)HK$1.79B
Price to Earnings (P/E)2.8
Beta0.07
Next Earnings
Aug 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.14
Shares Outstanding1,683,277,100
10 Day Avg. Volume3,078,640
30 Day Avg. Volume8,433,551
Financial Highlights & Ratios
PEG Ratio-0.06
Price to Book (P/B)-1.36
Price to Sales (P/S)0.31
P/FCF Ratio-24.77
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Diversified Corn-based Product MixGlobal Bio-chem sells a range of corn-derived products (amino acids, food additives, industrial co-products). This diversified product mix anchors demand across animal nutrition, food and industrial end-markets, reducing single-market risk and supporting structural revenue sources over a multi‑quarter horizon.
Positive Reported Net Income RecentlyThe company reported positive net income over multiple recent years, which provides a recurring accounting profit buffer that can help meet obligations and support refinancing options. While partly driven by non-operating items, sustained net profits improve long‑term solvency prospects versus chronic losses.
Multi-year Revenue Growth MetricFundamentals show multi-year revenue growth (~13.9%), indicating the business can expand sales over time. That trend reflects market demand for amino acids and related products and suggests underlying commercial traction and scale potential despite recent volatility.
Bears Say
Negative Shareholders' EquityNegative shareholders' equity is a structural balance-sheet weakness that raises insolvency risk and constrains strategic options. With equity below zero the firm has limited loss-absorbing capacity, higher refinancing risk, and reduced ability to fund capex or weather commodity shocks over the coming quarters.
Inconsistent And Negative Cash GenerationOperating cash flow has been inconsistent and recently negative, and free cash flow is also negative. Weak cash conversion undermines the firm’s ability to self-fund operations and capex, increasing reliance on external financing and elevating long-term liquidity and refinancing risk.
Negative EBIT And Thin Gross MarginsPersistently negative EBIT and narrow gross margins reduce resilience to input-cost swings (corn, energy) and limit internal reinvestment. Weak operating profitability signals the business struggles to convert sales into sustainable operating cash, making growth funding and margin recovery harder.
Global Bio-chem Technology Group Co. Ltd. News
0809 FAQ
What was Global Bio-chem Technology Group Co. Ltd.’s price range in the past 12 months?
Global Bio-chem Technology Group Co. Ltd. lowest stock price was HK$0.33 and its highest was HK$1.22 in the past 12 months.
What is Global Bio-chem Technology Group Co. Ltd.’s market cap?
Global Bio-chem Technology Group Co. Ltd.’s market cap is HK$557.16M.
When is Global Bio-chem Technology Group Co. Ltd.’s upcoming earnings report date?
Global Bio-chem Technology Group Co. Ltd.’s upcoming earnings report date is Aug 27, 2026 which is in 55 days.
How were Global Bio-chem Technology Group Co. Ltd.’s earnings last quarter?
Global Bio-chem Technology Group Co. Ltd. released its earnings results on Mar 27, 2026. The company reported HK$0.319 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.319.
Is Global Bio-chem Technology Group Co. Ltd. overvalued?
According to Wall Street analysts Global Bio-chem Technology Group Co. Ltd.’s price is currently Overvalued.
Does Global Bio-chem Technology Group Co. Ltd. pay dividends?
Global Bio-chem Technology Group Co. Ltd. pays a Semiannually dividend of HK$0.2 which represents an annual dividend yield of N/A. See more information on Global Bio-chem Technology Group Co. Ltd. dividends here
What is Global Bio-chem Technology Group Co. Ltd.’s EPS estimate?
Global Bio-chem Technology Group Co. Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Global Bio-chem Technology Group Co. Ltd. have?
Global Bio-chem Technology Group Co. Ltd. has 1,683,277,100 shares outstanding.
What happened to Global Bio-chem Technology Group Co. Ltd.’s price movement after its last earnings report?
Global Bio-chem Technology Group Co. Ltd. reported an EPS of HK$0.319 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.503%.
Which hedge fund is a major shareholder of Global Bio-chem Technology Group Co. Ltd.?
Currently, no hedge funds are holding shares in HK:0809
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Global Bio-chem Technology Group Co. Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-8.23%
12-Months-Change
Fundamentals
Return on Equity
-11.47%
Trailing 12-Months
Asset Growth
1.69%
Trailing 12-Months
Company Description
Global Bio-chem Technology Group Co. Ltd.
Global Bio-chem Technology Group Company Limited, an investment holding company, manufactures and sells corn refined products and corn-based biochemical products in the People's Republic of China, Asia, the Americas, and internationally. It operates through four segments: Upstream Products, Amino Acids, Corn Sweeteners, and Polyol Chemicals. The company offers corn refined products, including corn oil, corn steep liquor, corn starch, waxy corn starch, corn gluten meals, feed pellets, and corn germ cakes. It also provides downstream corn based biochemical products, such as amino acids comprising lysine, protein lysine, threonine, and glutamic acid; corn sweeteners, which include high fructose corn syrup, maltodextrin, high maltose syrup, maltose syrup, sorbitol, glucose, and crystallized glucose; modified starches; and chemicals, such as ethylene, propylene, and butylene glycols, as well as resins. In addition, the company offers polyol chemicals, anti-freeze products, hydrogen, and ammonia. Its products are used in various applications, such as feed production, food and beverage, cosmetics, textiles, pharmaceuticals, chemical industries, etc. The company was founded in 1994 and is headquartered in Hung Hom, Hong Kong.
Technical Analysis
Global Sweeteners Holdings Limited
―
Natural Food International Holding Ltd.
―
Vedan International (Holdings) Ltd.
―
China Starch Holdings Limited
―
Asia Cassava Resources Holdings Limited
―
Options Prices
Currently, No data available
---